| (210) | Number of the EPO application | 16759417 |
| (220) | Filing date of the EPO application | 2016.03.02 |
| (80) | EPO patent specification publication (B) | EPB nr. 47/2023, 2023.11.22 |
| (110) | EPO patent number | 3265084 |
| (11) | Number of the document | MD 3265084 T2 |
| (21) | Number of the application | e 2018 0058 |
| (71) | Name(s) of applicant(s), code of the country | PHARMACYCLICS LLC, US; |
| (72) | Name(s) of inventor(s), code of the country | ATLURI Harisha, US;
CHONG Ching Wah, US;
KUEHL Robert, US;
TAN Heow, US; |
| (73) | Name(s) of owner(s), code of the country | PHARMACYCLICS LLC, US; |
| (54) | Title of the invention | Pharmaceutical formulations of Bruton's tyrosine kinase inhibtor |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 31/436 (2006.01.01); A61K 31/519 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.03.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2024.05.31 |
| (30) | Priority | 201562127717 P, 2015.03.03, US; 201562193518 P, 2015.07.16, US |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2016/020467, 2016.03.02 |
| (87) | International publication | WO 2016/141068, 2016.09.09 |